These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 33415560)

  • 1. ASO Author Reflections: Age Is an Important Determinant of Concordance Between 21-Gene Recurrence Scores in Multiple Ipsilateral Breast Carcinomas.
    Pawloski KR; Tadros AB; El-Tamer M
    Ann Surg Oncol; 2021 Aug; 28(8):4263-4264. PubMed ID: 33415560
    [No Abstract]   [Full Text] [Related]  

  • 2. ASO Author Reflections: Surgical De-escalation for the Management of Ipsilateral Breast Cancer Recurrence in the Modern Era of Multimodality Treatment.
    Tasoulis MK; Karakatsanis A
    Ann Surg Oncol; 2022 Oct; 29(10):6454-6455. PubMed ID: 35904652
    [No Abstract]   [Full Text] [Related]  

  • 3. Multicentric Ipsilateral Invasive Breast Carcinomas Might have Higher 21-Gene Recurrence Score Compared with Multifocal Ipsilateral Invasive Breast Carcinomas.
    Altundag K
    Ann Surg Oncol; 2019 Jan; 26(1):309. PubMed ID: 30456675
    [No Abstract]   [Full Text] [Related]  

  • 4. ASO Author Reflections: The Strengths and Weaknesses of Intraoperative Radiotherapy for Early Breast Cancer and Ipsilateral Tumor Recurrence.
    Sawaki M; Kodaira T; Iwata H
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):660-661. PubMed ID: 31359282
    [No Abstract]   [Full Text] [Related]  

  • 5. ASO Author Reflections: Local Recurrence Risk and Risk Factors of Breast Phyllodes Tumors.
    Song E; Jacobs L; Chen K
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):637-638. PubMed ID: 31209669
    [No Abstract]   [Full Text] [Related]  

  • 6. ASO Author Reflections: Breast Cancer Local Recurrence Versus New Primary-Clinical Predictors and Prognostic Implications.
    Laird J; Braunstein LZ
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):648-649. PubMed ID: 30306376
    [No Abstract]   [Full Text] [Related]  

  • 7. ASO Author Reflections: Predicting High-Risk Oncotype DX Recurrence Scores as a Strategy for Assessing Neoadjuvant Chemotherapy Eligibility.
    Newman L
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):683-684. PubMed ID: 30377915
    [No Abstract]   [Full Text] [Related]  

  • 8. ASO Author Reflections: 21-Gene Recurrence Scores in Male Breast Cancer.
    Altman AM; Marmor S
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):669-670. PubMed ID: 30374927
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of multiple oncotype DX
    Marumoto AD; Mohan SC; Angarita SAK; Srour MK; Norton VE; Dadmanesh F; Giuliano AE
    Breast J; 2021 Nov; 27(11):828-831. PubMed ID: 34514676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ASO Author Reflections: Effect Sizes of Whole Breast Radiotherapy and Systemic Therapies on Regional Recurrence Incidence in Breast Cancer Patients.
    van Steenhoven JEC; van Dalen T
    Ann Surg Oncol; 2020 Sep; 27(9):3412-3413. PubMed ID: 32248377
    [No Abstract]   [Full Text] [Related]  

  • 11. ASO Author Reflections: Routine Radiologic Staging of Distant Metastases Must Be Recommended as a Binding Guideline After Diagnosis of Local Breast Cancer Recurrence.
    Güth U
    Ann Surg Oncol; 2019 Oct; 26(11):3462-3463. PubMed ID: 31313032
    [No Abstract]   [Full Text] [Related]  

  • 12. ASO Author Reflections: Clinical Implication of Nomograms in the Breast Oncology Field.
    Corso G
    Ann Surg Oncol; 2020 Jun; 27(6):1875-1876. PubMed ID: 32103418
    [No Abstract]   [Full Text] [Related]  

  • 13. ASO Author Reflections: Meta-Analysis of Local Recurrence of Invasive Breast Cancer After Electron Intraoperative Radiotherapy.
    Harness JK; Shah C
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):632-633. PubMed ID: 30264253
    [No Abstract]   [Full Text] [Related]  

  • 14. ASO Author Reflections: The Multidisciplinary Approach to de Novo Metastatic Inflammatory Breast Cancer: A Combined Systemic and Locoregional Strategy.
    Postlewait LM; Lucci A
    Ann Surg Oncol; 2021 Aug; 28(8):4275-4276. PubMed ID: 33404772
    [No Abstract]   [Full Text] [Related]  

  • 15. ASO Author Reflections: Impact of Resection Volume on Risk of Local Recurrence-The OPBC-01/iTOP2 Study.
    Montagna G; Weber WP; Geroldinger A; Fitzal F
    Ann Surg Oncol; 2022 Feb; 29(2):1071-1072. PubMed ID: 34581921
    [No Abstract]   [Full Text] [Related]  

  • 16. ASO Author Reflections: Use of Breast Imaging After Treatment for Locoregional Breast Cancer (AFT-01).
    Adesoye T; Schumacher J; Greenberg CC
    Ann Surg Oncol; 2019 Dec; 26(Suppl 3):553-554. PubMed ID: 30565039
    [No Abstract]   [Full Text] [Related]  

  • 17. ASO Author Reflections: The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-analysis.
    Shah C; Vicini F
    Ann Surg Oncol; 2020 Dec; 27(Suppl 3):680-681. PubMed ID: 32705518
    [No Abstract]   [Full Text] [Related]  

  • 18. ASO Author Reflections: Undertreatment of Early-Stage Breast Cancer in Elderly Women Undergoing Lumpectomy Without Radiotherapy Increases the Risk of Locoregional Recurrence.
    Matar R; Morrow M
    Ann Surg Oncol; 2022 Aug; 29(8):4761-4762. PubMed ID: 35451726
    [No Abstract]   [Full Text] [Related]  

  • 19. ASO Author Reflections: Gene Signature Generated from Tumor Budding-A New Molecular Marker of Recurrence Risk.
    Shinto E; Yoshida Y; Ueno H
    Ann Surg Oncol; 2020 Oct; 27(10):4055-4056. PubMed ID: 32342297
    [No Abstract]   [Full Text] [Related]  

  • 20. ASO Author Reflections: Is Intensifying Loco-Regional Treatment in the Early Course of De Novo Stage IV Breast Cancer Reasonable?
    Soran A
    Ann Surg Oncol; 2018 Dec; 25(Suppl 3):663-664. PubMed ID: 30357577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.